-
BREAKING THE BOTTLENECK: A NOVEL HUMAN+AI PROCESS FOR GENERATING FULLY-ANNOTATED, FOUNDATIONAL-DRAFT PRO MANUSCRIPTS FROM SOURCE MATERIALS IN UNDER 48 HOURS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SUBCUTANEOUS MOSUNETUZUMAB PLUS POLATUZUMAB VEDOTIN VERSUS RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN FOR UNITED STATES (US) PATIENTS WITH AUTOLOGOUS STEM CELL TRANSPLANT-INELIGIBLE RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF DIABETES MANAGEMENT STRATEGIES: INSIGHTS FROM PATIENT GLUCOSE CONTROL TRAJECTORIESLITHUANIAN NATIONAL HEALTH INSURANCE FUND'S ADMINISTRATIVE DATA
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS OF DIABETES MELLITUS: A RETROSPECTIVE REAL-WORLD COST-OF-ILLNESS ANALYSIS IN BRAZIL
Mar 18, 2026, 21:38 PM -
DO MULTIPLE PRESENTATIONS AFFECT THE DURATION OF U.S. DRUG SHORTAGES?
Mar 18, 2026, 21:38 PM -
ASSOCIATION OF FATIGUE AND ACUTE PAIN WITH HEALTH CARE RESOURCE UTILIZATION AND COSTS IN SICKLE CELL DISEASE IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
A QUALITATIVE STUDY TO EXPLORE PATIENT PERSPECTIVES ON FUTURE GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY (LGMD) SARCOGLYCANOPATHY SUBTYPES 2E/R4, 2D/R3, AND 2C/R5
Mar 18, 2026, 21:38 PM -
WHEN ADHERENCE ESTIMATES DIFFER: THE IMPACT OF DATA SOURCE AND GAP HANDLING IN REAL-WORLD MEDICATION USE ASSESSMENT
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SEMAGLUTIDE FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
INTERSECTIONAL ECONOMIC AND BEHAVIORAL DETERMINANTS OF ART AND ANTIDEPRESSANT ADHERENCE AMONG AFRICAN AMERICAN WOMEN LIVING WITH HIV: IMPLICATIONS FOR POLICY, ACCESS, VALUE, AND HEOR INNOVATION
Mar 18, 2026, 21:38 PM -
CONSENSUS ON BARRIERS AND UNMET NEEDS IN HEMOPHILIA CARE IN BRAZIL: A MODIFIED DELPHI STUDY
Mar 18, 2026, 21:38 PM -
COMPARING INFECTION OUTCOMES AND ANTIBIOTIC USE IN ADMINISTRATIVE CLAIMS FOLLOWING CYSTOURETHROSCOPY WITH SINGLE USE VERSUS REUSABLE SCOPES
Mar 18, 2026, 21:38 PM -
SOCIAL DETERMINANTS OF HEALTH, MORTALITY, AND EXTENDED HOSPITAL STAY IN ATRIAL FIBRILLATION: LEVERAGING OPEN-SOURCE LARGE LANGUAGE MODELS
Mar 18, 2026, 21:38 PM -
ESTIMATINGTHE EFFECTS OF VARIED VACCINATION COVERAGE LEVELS ON A MEASLES OUTBREAK IN AN ISOLATED POPULATION
Mar 18, 2026, 21:38 PM -
EARLY IDENTIFICATION AND MANAGEMENT OF POST-CARDIAC SURGERY COMPLICATIONS: IMPLICATIONS FOR CLINICAL PRACTICE, CARDIO-ONCOLOGY, AND HEALTH ECONOMICS
Mar 18, 2026, 21:38 PM -
DYNAMIC PRICING IN THE CONTEXT OF COST-EFFECTIVENESS MODELING AND WILLINGNESS-TO-PAY THRESHOLDS
Mar 18, 2026, 21:38 PM -
SOCIAL MEDIA SENTIMENT TOWARD ANTI-AMYLOID THERAPIES IN EARLY ALZHEIMER’S DISEASE: IMPLICATIONS FOR REAL-WORLD EVIDENCE AND DECISION-MAKING
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH EXTERNAL BEAM RADIATION THERAPY
Mar 18, 2026, 21:38 PM -
INTEGRATING MACHINE LEARNING AND GENERATIVE AI ACROSS THE SYSTEMATIC REVIEW WORKFLOW - AN AI-ENHANCED SLR OF POST AMI CARDIOVASCULAR RISK AND CARDIOVASCULAR INFLAMMATION
Mar 18, 2026, 21:38 PM -
PRE-APPROVAL INFORMATION EXCHANGE (PIE) IN THE UNITED STATES. TRENDS FOLLOWING THE PASSAGE OF THE PIE ACT: WHERE ARE WE NOW?
Mar 18, 2026, 21:38 PM
